НовостиBenzingaJefferies Initiates Coverage On Mentari Therapeutics with Buy Rating, Announces Price Target of $30 Jefferies Initiates Coverage On Mentari Therapeutics with Buy Rating, Announces Price Target of $30 Benzinga 2026.11.10 14:26 (GMT+0) Открыть на Benzinga Другие новости